Form 4: Blend Labs Principal Accounting Officer Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Blend Labs' Principal Accounting Officer, Oxana Tkach, sold 18,324 shares of Class A Common Stock at an average price of $5.176 per share on November 25, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- Oxana Tkach, the Principal Accounting Officer of Blend Labs, sold 18,324 shares of Class A Common Stock on November 25, 2024.
- The sale was executed under a Rule 10b5-1 trading plan adopted on May 24, 2024.
- The shares were sold at a weighted average price of $5.176, with individual prices ranging from $5.09 to $5.275 per share.
- Following the transaction, Ms. Tkach directly owns 88,677 shares of Blend Labs Class A Common Stock.
Sentiment
Score: 5
Explanation: The document reflects a routine insider transaction under a pre-arranged plan, which is neither positive nor negative for the company's outlook. It's a neutral event.
Industry Context
This is a routine filing related to insider trading activity and is common for publicly traded companies. The use of a 10b5-1 plan indicates the sale was pre-planned and not based on any material non-public information.
Comparison to Industry Standards
- The use of a 10b5-1 trading plan is a common practice among executives at publicly traded companies to avoid accusations of insider trading.
- Similar filings are regularly made by officers and directors of companies like Upstart, Rocket Companies, and other fintech firms.
- The volume of shares sold is relatively small compared to the overall outstanding shares of Blend Labs, suggesting it is a personal financial decision rather than a significant market event.
Stakeholder Impact
- The sale of shares by a company officer may have a minor impact on investor sentiment, but the pre-planned nature of the transaction mitigates any significant concerns.
Key Dates
| Date | Description |
|---|---|
| 05/24/2024 | Date the Rule 10b5-1 trading plan was adopted by Oxana Tkach. |
| 11/25/2024 | Date of the stock sale transaction. |
| 11/26/2024 | Date the Form 4 was signed. |
Keywords
Form 4, insider trading, 10b5-1 plan, stock sale, Blend Labs, BLND, Oxana Tkach, Principal Accounting Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.